Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (101-110 of 542) with videos related to

Pageof 55
Sort By:
Journal of Clinical Microbiology|October 9, 2004
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazoleM A Pfaller, A Espinel-Ingroff, R N Jones
Diagnostic Microbiology and Infectious Disease|December 1, 1994
Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing EnterobacteriaceaeH S Sader, M A Pfaller, R N Jones
Diagnostic Microbiology and Infectious Disease|January 1, 1995
Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosisM A Pfaller, S A Messer, R J Hollis
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection seasonR N Jones, M A Pfaller, G V Doern
Antimicrobial Agents and Chemotherapy|January 1, 1993
Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acidA L Barry, P C Fuchs, M A Pfaller
The Annals of Pharmacotherapy|January 7, 1999
Therapy of Candida infections: susceptibility testing, resistance, and therapeutic optionsM E Klepser, R E Lewis, M A Pfaller
Journal of Clinical Microbiology|September 1, 1994
Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazoleD L Sewell, M A Pfaller, A L Barry
The Journal of Antimicrobial Chemotherapy|May 13, 1998
Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformansM E Klepser, E J Wolfe, M A Pfaller
Clinical Microbiology Reviews|April 16, 2004
Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardizationM A Pfaller, D J Sheehan, J H Rex
Journal of Clinical Microbiology|February 13, 1999
Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospitalY F Berrouane, L A Herwaldt, M A Pfaller
Pageof 55

Showing results (101-110 of 542) with videos related to

Sort By:
Pageof 55
Journal of Clinical Microbiology|October 9, 2004
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazoleM A Pfaller, A Espinel-Ingroff, R N Jones
Diagnostic Microbiology and Infectious Disease|December 1, 1994
Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing EnterobacteriaceaeH S Sader, M A Pfaller, R N Jones
Diagnostic Microbiology and Infectious Disease|January 1, 1995
Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosisM A Pfaller, S A Messer, R J Hollis
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection seasonR N Jones, M A Pfaller, G V Doern
Antimicrobial Agents and Chemotherapy|January 1, 1993
Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acidA L Barry, P C Fuchs, M A Pfaller
The Annals of Pharmacotherapy|January 7, 1999
Therapy of Candida infections: susceptibility testing, resistance, and therapeutic optionsM E Klepser, R E Lewis, M A Pfaller
Journal of Clinical Microbiology|September 1, 1994
Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazoleD L Sewell, M A Pfaller, A L Barry
The Journal of Antimicrobial Chemotherapy|May 13, 1998
Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformansM E Klepser, E J Wolfe, M A Pfaller
Clinical Microbiology Reviews|April 16, 2004
Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardizationM A Pfaller, D J Sheehan, J H Rex
Journal of Clinical Microbiology|February 13, 1999
Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospitalY F Berrouane, L A Herwaldt, M A Pfaller
Pageof 55